Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
42.32-0.83 (-1.92%)
At close: 4:00 PM EDT

42.32 0.00 (0.00%)
After hours: 5:07 PM EDT

People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close43.15
Bid42.37 x 100
Ask42.59 x 100
Day's Range42.11 - 43.10
52wk Range41.67 - 66.55
1y Target EstN/A
Market Cap38.68B
P/E Ratio (ttm)28.27
Avg Vol (3m)6,686,004
Dividend & Yield1.36 (3.14%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Investopediayesterday

    Teva, IBM Expand Drug Repurposing Plan (TEVA, IBM)

    Teva and IBM expanded their disease management and drug repurposing alliance.

  • Exactly How Bad Is Regeneron's Latest News?
    Motley Fool2 days ago

    Exactly How Bad Is Regeneron's Latest News?

    Is the recent setback for fasinumab a mountain or a molehill for Regeneron?

  • American City Business Journals2 days ago

    Teva, IBM expand Watson supercomputer partnership

    Teva Pharmaceutical Industries Ltd. and IBM said Wednesday they are "significantly expanding" their Watson Health alliance. Watson is IBM's supercomputer that combines artificial intelligence and sophisticated analytical software. The expansion of Teva (TEVA) and IBM's three-year partnership will focus on two key health care challenges: the discovery of new treatment options and improving chronic disease management.